Paper2869486
Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity.
Staerz UD and 1 other. Proc Natl Acad Sci U S A, 1986. Cited by 207 papers, by iCite.
Cite this record
ConductScience Library. Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity. Papers, record 2869486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2869486
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Antigens, Surface | Major topic |
| Receptors, Antigen, T-Cell | Major topic |
| T-Lymphocytes, Cytotoxic | Major topic |
| Animals | |
| Antibody Specificity | |
| Cytotoxicity, Immunologic | |
| Hybridization, Genetic | |
| Immunity, Cellular | |
| Immunoglobulin Fab Fragments | |
| Mice | |
| Thy-1 Antigens |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AI19335 | NIAID NIH HHS | United States | R01AI019335 | PubMed and NIH | NIH RePORTER |
| CA25803 | NCI NIH HHS | United States | P01CA025803 | PubMed and NIH | NIH RePORTER |
| R37AI019335 | NIH | NIH RePORTER |
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4972125 | Use of hybrid antibody with anti-gamma-G and anti-ferritin specificities in locating cell surface antigens by electron microscopy. | J Exp Med | 1968 | https://conductscience.org/library/papers/4972125 | PubMed |
| 2 | 13729244 | Recombination of a mixture of univalent antibody fragments of different specificity. | Arch Biochem Biophys | 1961 | https://conductscience.org/library/papers/13729244 | PubMed |
| 3 | 1172191 | Continuous cultures of fused cells secreting antibody of predefined specificity. | Nature | 1975 | https://conductscience.org/library/papers/1172191 | PubMed |
| 4 | 818397 | Specific interaction between VH and VL regions of human monoclonal immunoglobulins. | J Mol Biol | 1976 | https://conductscience.org/library/papers/818397 | PubMed |
| 5 | 821618 | Somatic cell hybridization of mouse myeloma cells. | Cell | 1976 | https://conductscience.org/library/papers/821618 | PubMed |
| 6 | 30693 | Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. | Immunochemistry | 1978 | https://conductscience.org/library/papers/30693 | PubMed |
| 7 | 6965328 | Mouse leukemia: therapy with monoclonal antibodies against a thymus differentiation antigen. | Science | 1980 | https://conductscience.org/library/papers/6965328 | PubMed |
| 8 | 7391580 | Specific in vivo localization of monoclonal antibodies directed against the Thy 1.1 antigen. | J Immunol | 1980 | https://conductscience.org/library/papers/7391580 | PubMed |
| 9 | 6181166 | Tumor-specific antigen of murine T-lymphoma defined with monoclonal antibody. | J Immunol | 1982 | https://conductscience.org/library/papers/6181166 | PubMed |
| 10 | 6185617 | Clonotypic structures involved in antigen-specific human T cell function. Relationship to the T3 molecular complex. | J Exp Med | 1983 | https://conductscience.org/library/papers/6185617 | PubMed |
| 11 | 6601175 | The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody. | J Exp Med | 1983 | https://conductscience.org/library/papers/6601175 | PubMed |
| 12 | 6604124 | Idiotype-like molecules on cells of a human T cell leukemia. | J Exp Med | 1983 | https://conductscience.org/library/papers/6604124 | PubMed |
| 13 | 6604129 | Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones. | J Exp Med | 1983 | https://conductscience.org/library/papers/6604129 | PubMed |
| 14 | 6413583 | Biosynthesis, glycosylation, and in vitro translation of the human T cell antigen Leu-4. | J Immunol | 1983 | https://conductscience.org/library/papers/6413583 | PubMed |
| 15 | 6137772 | Hybrid hybridomas and their use in immunohistochemistry. | Nature | 1983 | https://conductscience.org/library/papers/6137772 | PubMed |
| 16 | 6227478 | Biosynthesis and molecular nature of the T3 antigen of human T lymphocytes. | EMBO J | 1983 | https://conductscience.org/library/papers/6227478 | PubMed |
| 17 | 6358356 | On the fragmentation of monoclonal IgG1, IgG2a, and IgG2b from BALB/c mice. | J Immunol | 1983 | https://conductscience.org/library/papers/6358356 | PubMed |
| 18 | 6328306 | Somatic recombination in a murine T-cell receptor gene. | Nature | 1984 | https://conductscience.org/library/papers/6328306 | PubMed |
| 19 | 6206178 | The antigen-specific, major histocompatibility complex-restricted receptor on T cells. VI. An antibody to a receptor allotype. | J Exp Med | 1984 | https://conductscience.org/library/papers/6206178 | PubMed |
| 20 | 6090932 | The structure, rearrangement and expression of D beta gene segments of the murine T-cell antigen receptor. | Nature | 1984 | https://conductscience.org/library/papers/6090932 | PubMed |
Cited by51
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 207 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42729476 | An Overview on T-Cell Engagers: The Current Position in Both the Biological and Mathematical Context. | Comput Struct Biotechnol J | 2026 | https://conductscience.org/library/papers/42729476 | PubMed |
| 42380631 | T cell engagers in autoimmune diseases. | Nat Rev Immunol | 2026 | https://conductscience.org/library/papers/42380631 | PubMed |
| 41262250 | Bispecific immunotherapy based on antibodies, T-cell receptors, and aptamers: mechanisms of action, adverse effects, and future perspectives. | Front Immunol | 2025 | https://conductscience.org/library/papers/41262250 | PubMed |
| 41096731 | Special Issue: Antibody Therapy for Hematologic Malignancies. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41096731 | PubMed |
| 39172329 | Clinical Progresses and Challenges of Bispecific Antibodies for the Treatment of Solid Tumors. | Mol Diagn Ther | 2024 | https://conductscience.org/library/papers/39172329 | PubMed |
| 39054343 | CD28 co-stimulation: novel insights and applications in cancer immunotherapy. | Nat Rev Immunol | 2024 | https://conductscience.org/library/papers/39054343 | PubMed |
| 36877356 | Antibody-drug conjugates and bispecific antibodies targeting cancers: applications of click chemistry. | Arch Pharm Res | 2023 | https://conductscience.org/library/papers/36877356 | PubMed |
| 36685546 | The making of multivalent gamma delta TCR anti-CD3 bispecific T cell engagers. | Front Immunol | 2022 | https://conductscience.org/library/papers/36685546 | PubMed |
| 34874513 | Emerging immunological strategies: recent advances and future directions. | Front Med | 2021 | https://conductscience.org/library/papers/34874513 | PubMed |
| 32786324 | Rapid Assembly and Screening of Multivalent Immune Cell-Redirecting Therapies for Leukemia. | ACS Comb Sci | 2020 | https://conductscience.org/library/papers/32786324 | PubMed |
| 32659909 | Bispecific Antibodies: A New Era of Treatment for Multiple Myeloma. | J Clin Med | 2020 | https://conductscience.org/library/papers/32659909 | PubMed |
| 32296187 | Multispecific drugs herald a new era of biopharmaceutical innovation. | Nature | 2020 | https://conductscience.org/library/papers/32296187 | PubMed |
| 32111076 | Bispecific Antibodies and Antibody-Drug Conjugates for Cancer Therapy: Technological Considerations. | Biomolecules | 2020 | https://conductscience.org/library/papers/32111076 | PubMed |
| 31544847 | Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells. | Antibodies (Basel) | 2019 | https://conductscience.org/library/papers/31544847 | PubMed |
| 30280288 | Bispecific Antibodies for the Treatment of Acute Myeloid Leukemia. | Curr Hematol Malig Rep | 2018 | https://conductscience.org/library/papers/30280288 | PubMed |
| 30197788 | New developments in immunotherapy for lymphoma. | Cancer Biol Med | 2018 | https://conductscience.org/library/papers/30197788 | PubMed |
| 30132211 | Expanding the Boundaries of Biotherapeutics with Bispecific Antibodies. | BioDrugs | 2018 | https://conductscience.org/library/papers/30132211 | PubMed |
| 29118005 | Redirecting T cells to hematological malignancies with bispecific antibodies. | Blood | 2018 | https://conductscience.org/library/papers/29118005 | PubMed |
| 29018834 | In Situ Liver Expression of HBsAg/CD3-Bispecific Antibodies for HBV Immunotherapy. | Mol Ther Methods Clin Dev | 2017 | https://conductscience.org/library/papers/29018834 | PubMed |
| 27916996 | A New Agent in the Strategy to Cure AIDS. | Mol Ther | 2016 | https://conductscience.org/library/papers/27916996 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2869486
GET https://conductscience.org/api/papers/v1/2869486/references?page=2